Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

The Wilkerson Group Inc.

Latest From The Wilkerson Group Inc.

Japan Trading Firm Establishes $459 Million Drug R&D Fund

Japan drug makers are getting a new research-and-development source in the form of trading company Mitsui & Co., which has established a $459 million investment fund, which it would seed with $100 million.

BioPharmaceutical Japan

Beware Patent Trolls: Personal Care Faces Rise In Opportunistic Suits

Suits filed by non-practicing entities, or “patent trolls,” against non-tech companies – including personal-care firms – have roughly doubled over the past five years, Hogan Lovells patent attorney Celine Crowson tells “The Rose Sheet.” Industry and legislators are looking to combat such suits, which accounted for 56% of all patent litigation filed in 2012.

Quintiles Founder Forecasts China Will Be Drug R&D Leader

China is on its way to becoming a global force in life-sciences innovation, fulfilling a forecast two years ago by Dennis Gillings, founder of Quintiles, a U.S.-based contract research organization.

China Emerging Markets

Pharmacy Giant Qol Acquires Apoplus, Enters CSO Market

Leading dispensing pharmacy Qol announced Oct. 15 it has acquired shares of Apoplus Station, a company specializing in pharmacist recruitment and the CSO industry.

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Services